Find the Perfect Plan for Your Investment Journey
N
Latest price
52 Week Range
€2.16 - €10.35
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | €56.60M |
EV | €58.10M |
Shares Outstanding | 7.71M |
Beta | 0.60 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | €9.00 |
P/E 2025E | 16.29x |
P/Revenue 2025E | 3.56x |
Revenue | 10.90% |
EPS | 2.40% |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 35.40% |
EPS | - |
Operating Cash Flow | 59.30% |
Free Cash Flow | 233.40% |
Gross Margin 2025E | - |
Net Profit Margin 2025E | 21.52% |
ROE 2025E | 93.20% |
ROCE 2024 | -27.30% |
DPS 2025E | €0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
N
Nexstim Plc
NXTMH
Sector
Healthcare
Industry
Medical - Devices
CEO
Karvinen, Mikko
Employees
40
Website
www.nexstim.comIPO Date
2014-11-14
Headquarters
ElimAeenkatu 9 B, Helsinki, Uusimaa, 00510, Finland
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved